Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
105

Summary

Conditions
  • Gastric Cancer
  • Cervical Cancer
  • Small Cell Lung Cancer
  • Colorectal Cancer
  • Urothelial Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Hepatocellular Carcinoma
  • Melanoma
  • Merkel Cell Carcinoma
  • Microsatellite Instability
  • Mismatch Repair Deficiency
  • Non -Small Cell Lung Cancer
  • Renal Cell Carcinoma
Type
Interventional
Phase
Phase 2
Design
Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03228667
Collaborators
Not Provided
Investigators
Study Director: Chad Garner, PhD ImmunityBio, Inc.